Cardioprotective effects of the YiQiFuMai injection and isolated compounds on attenuating chronic heart failure via NF-κB inactivation and cytokine suppression

Journal of Ethnopharmacology

Volumn 148, Issue 1, 2013, Pages 239-245

  Xing, Lu ^a   Jiang, Min ^a   Dong, Linyi ^c   Gao, Jie ^a   Hou, Yuanyuan ^a   Bai, Gang ^a   Luo, Guoan ^a,b  

^a NANKAI UNIVERSITY   (China)

^b TSINGHUA UNIVERSITY   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Anti inflammatory; Chronic heart failure; Ginsenoside; NF B; YiQiFuMai injection

Indexed keywords

ANTIINFLAMMATORY AGENT; CAPTOPRIL; CARDIOVASCULAR AGENT; CHIKUSETSU SAPONIN; CHINESE DRUG; CYTOKINE; GINSENOSIDE; GINSENOSIDE RB 1; GINSENOSIDE RB 2; GINSENOSIDE RC; GINSENOSIDE RF; GINSENOSIDE RG 1; GINSENOSIDE RG 3; GINSENOSIDE RH1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; YIQIFUMAI;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; HEART; HEART FAILURE; HEART FUNCTION; HEART PROTECTION; HEART RATE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARDIOTONIC AGENTS; CYTOKINES; DRUGS, CHINESE HERBAL; GINSENOSIDES; HEART FAILURE; HEK293 CELLS; HUMANS; MALE; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; RATTUS;

EID: 84878339842     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2013.04.019     Document Type: Article

References (41)

1. M.L. Batista Jr., R.D. Lopes, M.C. Seelaender, and A.C. Lopes Anti-inflammatory effect of physical training in heart failure: role of TNF-alpha and IL-10 Arquivos Brasileiros de Cardiologia 93 2009 692 700
2. B. Bozkurt, D.L. Mann, and A. Deswal Biomarkers of inflammation in heart failure Heart Failure Reviews 15 2010 331 341
3. A.M. Candia, H. Villacorta Jr., and E.T. Mesquita Immune-inflammatory activation in heart failure Arquivos Brasileiros de Cardiologia 89 2007 183 190
4. P.Y. Chiu, N. Chen, P.K. Leong, H.Y. Leung, and K.M. Ko Schisandrin B elicits a glutathione antioxidant response and protects against apoptosis via the redox-sensitive ERK/Nrf2 pathway in H9c2 cells Molecular and Cellular Biochemistry 350 2011 237 250
5. J.N. Cohn, R. Ferrari, and N. Sharpe Cardiac remodeling - concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling Journal of American Colloge Cardiology 35 2000 569 582
6. A. Deswal, N.J. Petersen, A.M. Feldman, J.B. Young, B.G. White, and D.L. Mann Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST) Circulation 103 2001 2055 2059
7. S. Frantz, D. Fraccarollo, H. Wagner, T.M. Behr, P. Jung, C.E. Angermann, G. Ertl, and J. Bauersachs Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure Cardiovascular Research 57 2003 749 756
8. K.G. Haeusler, U. Laufs, and M. Endres Chronic heart failure and ischemic stroke Stroke 42 2011 2977 2982
9. T. Hamid, Y. Gu, R.V. Ortines, C. Bhattacharya, G. Wang, Y.T. Xuan, and S.D. Prabhu Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation Circulation 119 2009 1386 1397
10. H. He, M. Shi, X. Zeng, J. Yang, Y. Li, L. Wu, and L. Li Cardioprotective effect of salvianolic acid B on large myocardial infarction mediated by reversing upregulation of leptin, endothelin pathways, and abnormal expression of SERCA2a, phospholamban in rats Journal of Ethnopharmacology 118 2008 35 45
11. M. Hedayat, M.J. Mahmoudi, N.R. Rose, and N. Rezaei Proinflammatory cytokines in heart failure: double-edged swords Heart Failure Reviews 15 2010 543 562
12. S. Heymans, E. Hirsch, S.D. Anker, P. Aukrust, J.L. Balligand, J.W. Cohen-Tervaert, H. Drexler, G. Filippatos, S.B. Felix, L. Gullestad, D. Hilfiker-Kleiner, S. Janssens, R. Latini, G. Neubauer, W.J. Paulus, B. Pieske, P. Ponikowski, B. Schroen, H.P. Schultheiss, C. Tschope, M. Van Bilsen, F. Zannad, J. McMurray, and A.M. Shah Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology European Journal of Heart Failure 11 2009 119 129
13. L. Jia, and Y. Zhao Current evaluation of the millennium phytomedicine - ginseng (I): etymology, pharmacognosy, phytochemistry, market and regulations Current Medicinal Chemistry 16 2009 2475 2484
14. P. Jongsun, and Y.C. Jae Anti-inflammatory effects of ginsenosides from Panax ginseng and their structural analogs African Journal of Biotechnology 8 2009 3682 3690
15. T.H. Kim, and S.M. Lee The effects of ginseng total saponin, panaxadiol and panaxatriol on ischemia/reperfusion injury in isolated rat heart Food and Chemical Toxicology 48 2010 1516 1520
16. P. Kleinbongard, R. Schulz, and G. Heusch TNFalpha in myocardial ischemia/reperfusion, remodeling and heart failure Heart Failure Reviews 16 2011 49 69
17. J. Kou, Y. Sun, Y. Lin, Z. Cheng, W. Zheng, B. Yu, and Q. Xu Anti-inflammatory activities of aqueous extract from Radix Ophiopogon japonicus and its two constituents Biological and Pharmaceutical Bulletin 28 2005 1234 1238
18. U. Landmesser, K.C. Wollert, and H. Drexler Potential novel pharmacological therapies for myocardial remodelling Cardiovascular Research 81 2009 519 527
19. D.C. Lee, and A.S. Lau Effects of Panax ginseng on tumor necrosis factor-alpha-mediated inflammation: a mini-review Molecules 16 2011 2802 2816
20. M. Li, D. Georgakopoulos, G. Lu, L. Hester, D.A. Kass, J. Hasday, and Y. Wang p38 MAP kinase mediates inflammatory cytokine induction in cardiomyocytes and extracellular matrix remodeling in heart Circulation 111 2005 2494 2502
21. J.M. Lu, Q. Yao, and C. Chen Ginseng compounds: an update on their molecular mechanisms and medical applications Current Vascular Pharmacology 7 2009 293 302
22. J.Y. Mao, B.L. Zhang, and X.L. Wang A review of developments in the mechanism of shenmai injecton for treating chronic heart failure Chinese Traditional Patent Medicine 12 2006 1801 1802
23. Y. Miao, W.J. Zhao, and L. Jing Retrospective analysis on integrative medicinal treatment of chronic heart failure Zhongguo Zhong Xi Yi Jie He Za Zhi 28 2008 406 409
24. W.L. Miller, K.A. Hartman, M.F. Burritt, D.E. Grill, R.J. Rodeheffer, J.C. Burnett Jr., and A.S. Jaffe Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time Circulation 116 2007 249 257
25. H. Nishida, H. Ichikawa, and T. Konishi Shengmai-san enhances antioxidant potential in C2C12 myoblasts through the induction of intracellular glutathione peroxidase Journal of Pharmacological Sciences 105 2007 342 352
26. S.Y. Oh, Y.H. Kim, D.S. Bae, B.H. Um, C.H. Pan, C.Y. Kim, H.J. Lee, and J.K. Lee Anti-inflammatory effects of gomisin N, gomisin J, and schisandrin C isolated from the fruit of Schisandra chinensis Bioscience, Biotechnology, and Biochemistry 74 2010 285 291
27. G.M. Pan, X. Zhou, X.G. Sheng, and G.Z. Yao Advantages and breakthrough point of TCM in the treatment of chronic heart failure Journal of Liaoning University of TCM 13 2011 44 45
28. A. Panossian, and G. Wikman Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine Journal of Ethnopharmacology 118 2008 183 212
29. R.C. Parish, and J.D. Evans Inflammation in chronic heart failure The Annals of Pharmacotherapy 42 2008 1002 1016
30. J.L. Rios Effects of triterpenes on the immune system Journal of Ethnopharmacology 128 2010 1 14
31. B.S. Seok, H.T. Nguyen, and H.Q. Tran Inhibition of TNF-α-mediated NF-κB transcriptional activity in HepG2 cells by Dammarane-type Saponins from Panax ginseng leaves Journal of Ginseng Review 2 2012 146 152
32. K. Swedberg, J. Cleland, H. Dargie, H. Drexler, F. Follath, M. Komajda, L. Tavazzi, O.A. Smiseth, A. Gavazzi, A. Haverich, A. Hoes, T. Jaarsma, J. Korewicki, S. Levy, C. Linde, J.L. Lopez-Sendon, M.S. Nieminen, L. Pierard, and W.J. Remme Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology European Heart Journal 26 2005 1115 1140
33. Y.Q. Tian, B.Y. Yu, and J.P. Kou Progress in pharmacological actions of Ophiopogon japonicus The Chinese Academic Medical Magazine of organisms 1671 2004 1 5
34. G. Valen, Z.Q. Yan, and G.K. Hansson Nuclear factor kappa-B and the heart Journal of the American College of Cardiology 38 2001 307 314
35. N. Wang, S. Minatoguchi, M. Arai, Y. Uno, Y. Nishida, K. Hashimoto, C. Xue-Hai, K. Fukuda, S. Akao, G. Takemura, and H. Fujiwara Sheng-Mai-San is protective against post-ischemic myocardial dysfunction in rats through its opening of the mitochondrial KATP channels Circulation Journal 66 2002 763 768
36. S.C. Wong, M. Fukuchi, P. Melnyk, I. Rodger, and A. Giaid Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure Circulation 98 1998 100 103
37. D.N. Xiao The status of safety study on traditional Chinese medicine injection Medical Recapitulate 14 2008 1715 1716
38. L.H. Xu Therapeutic effect of YiQiFuMai in patients with chronic congestive heart failure Medical Information 22 2009 2418 2419
39. H.Q. Yin, B. Wang, J.D. Zhang, H.Q. Lin, Y. Qiao, R. Wang, and F.Y. Liu Effect of traditional Chinese medicine Shu-Mai-Tang on attenuating TNFalpha-induced myocardial fibrosis in myocardial ischemia rats Journal of Ethnopharmacology 118 2008 133 139
40. S.M. Yuan, and H. Jing Insights into the monomers and single drugs of Chinese herbal medicine on myocardial preservation African Journal of Traditional, Complementary and Alternative Medicines 8 2011 104 127
41. J. Zhao, P. Jiang, and W. Zhang Molecular networks for the study of TCM pharmacology Briefings in Bioinformatics 11 2010 417 430